Over the several years that the CMS and hospitals have been tussling over the reasons behind the steady rise in short-term observation stays, no one until now has suggested the increase represents a deliberate effort by hospitals to avoid Medicare's 30-day readmission penalties.
The latest Kaiser Family Foundation tracking poll showed most Americans are more concerned about the rising price of drugs than repeal of the Affordable Care Act. But drug prices are not the only cost issue on peoples' minds.
Anyone concerned about unnecessary healthcare spending—and what system leader or insurer isn't these days?—should pay close attention to the drug industry's campaign to win the right to promote the off-label use of prescription drugs.
It doesn't matter how much healthcare providers and researchers rail about the inadequacy and inconsistency of the consumer ratings offered by the CMS, the Leapfrog Group, journalism outfits and online startups. They are not only here to stay, they are proliferating.
In what must have been a terrible disappointment for Obamacare bashers on the presidential campaign trail, the early returns from California suggest the rate increases next year in the individual and small-group health insurance market will be modest. The news comes with a caveat: Everything may...
The United States finances healthcare through a confusing hodgepodge of payment programs that send distorted signals to employers, insurers, providers and the general public.
Most senior citizens will fight fiercely to remain in their own homes, often well beyond their physical or even mental capacity to take care of themselves. A recent ACA-initiated demonstration program suggests there may be savings for Medicare if that's where seniors receive care.
Later this year, the U.S. Bureau of Labor Statistics will issue its first report measuring hospital productivity. It won't be good news.
For decades, the nation has poured hundreds of billions of dollars into basic and applied science to devise cures for diseases. But investing in research and development for new and better ways of delivering care in hospitals and physician offices remains a stepchild in Washington.
The healthcare industry heaved a collective sigh of relief last week after the U.S. Supreme Court upheld insurance subsidies in states using federally run exchanges. The 6-3 decision effectively puts an end to legal challenges to the Affordable Care Act.
Every once in a while, a study comes along that reminds us that a majority of the institutions we cover at Modern Healthcare are not-for-profits operating under government charters that absolve them from paying federal, state and local taxes.
The skirmishing ahead of the U.S. Supreme Court's King v. Burwell decision suggests we are in for a period of prolonged political turbulence should the high court strike down premium subsidies in the 34 states using the federally run exchanges.